Elbadr, M.M.; Galal, H.A.; Hetta, H.F.; Elfadil, H.; Alanazi, F.E.; Fawzy, S.; Aljohani, H.M.; Abd Ellah, N.H.; Ali, M.F.; Dyab, A.K.;
et al. Immunomodulatory Effect of Rivaroxaban Nanoparticles Alone and in Combination with Sitagliptin on Diabetic Rat Model. Diseases 2025, 13, 87.
https://doi.org/10.3390/diseases13030087
AMA Style
Elbadr MM, Galal HA, Hetta HF, Elfadil H, Alanazi FE, Fawzy S, Aljohani HM, Abd Ellah NH, Ali MF, Dyab AK,
et al. Immunomodulatory Effect of Rivaroxaban Nanoparticles Alone and in Combination with Sitagliptin on Diabetic Rat Model. Diseases. 2025; 13(3):87.
https://doi.org/10.3390/diseases13030087
Chicago/Turabian Style
Elbadr, Mohamed M., Heba A. Galal, Helal F. Hetta, Hassabelrasoul Elfadil, Fawaz E. Alanazi, Shereen Fawzy, Hashim M. Aljohani, Noura H. Abd Ellah, Marwa F. Ali, Ahmed K. Dyab,
and et al. 2025. "Immunomodulatory Effect of Rivaroxaban Nanoparticles Alone and in Combination with Sitagliptin on Diabetic Rat Model" Diseases 13, no. 3: 87.
https://doi.org/10.3390/diseases13030087
APA Style
Elbadr, M. M., Galal, H. A., Hetta, H. F., Elfadil, H., Alanazi, F. E., Fawzy, S., Aljohani, H. M., Abd Ellah, N. H., Ali, M. F., Dyab, A. K., & Ahmed, E. A.
(2025). Immunomodulatory Effect of Rivaroxaban Nanoparticles Alone and in Combination with Sitagliptin on Diabetic Rat Model. Diseases, 13(3), 87.
https://doi.org/10.3390/diseases13030087